Profusa Inc Financials
Financial Health Signals
Profusa Inc passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.
For every $1 of reported earnings, Profusa Inc generates $0.15 in operating cash flow (-$1.3M OCF vs -$8.7M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
This page shows Profusa Inc (NVACW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Profusa Inc reported -$8.7M in net income in fiscal year 2024. This represents a decrease of 849.8% from the prior year.
Profusa Inc earned $-1.47 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 1325.0% from the prior year.
Profusa Inc held $191K in cash against $0 in long-term debt as of fiscal year 2024.
Profusa Inc had 6M shares outstanding in fiscal year 2024. This represents a decrease of 4.6% from the prior year.
Profusa Inc spent $3.2M on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 98.2% from the prior year.
NVACW Income Statement
| Metric | Q3'25 | Q3'24 | Q4'23 | Q3'23 | Q4'22 | Q3'22 | Q4'21 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | $75K | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | $722K+75.7% | $411K | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $21.0M+2636.2% | $767K | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -$21.7M-1868.2% | -$1.1M | N/A | -$290K | N/A | -$404K | N/A | -$338 |
| Interest Expense | $169K-84.2% | $1.1M | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $2K-87.8% | $19K | N/A | $25K | N/A | $43K | N/A | N/A |
| Net Income | -$22.2M-788.7% | -$2.5M | N/A | -$367K | N/A | $1.8M | N/A | -$338 |
| EPS (Diluted) | $-0.70 | $-1.29 | N/A | $-0.06 | N/A | $0.05 | N/A | $0.00 |
NVACW Balance Sheet
| Metric | Q3'25 | Q3'24 | Q4'23 | Q3'23 | Q4'22 | Q3'22 | Q4'21 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.3M+38.3% | $3.1M-71.8% | $10.9M+0.7% | $10.8M-94.5% | $194.7M+0.5% | $193.8M+0.4% | $193.1M | N/A |
| Current Assets | $4.2M+1513.5% | $260K-83.5% | $1.6M+930.5% | $153K-70.1% | $512K-27.5% | $706K-35.8% | $1.1M | N/A |
| Cash & Equivalents | $3.0M+1475.4% | $191K+4126.6% | $5K-73.9% | $17K-91.0% | $193K-48.1% | $373K-49.7% | $741K | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $38.2M-68.8% | $122.3M+1.2% | $120.9M+746.0% | $14.3M-92.7% | $195.4M+0.6% | $194.2M-2.4% | $199.0M | N/A |
| Current Liabilities | $23.5M-58.8% | $57.1M+1060.8% | $4.9M+64.1% | $3.0M+220.5% | $936K+133.8% | $400K+275.8% | $107K | N/A |
| Long-Term Debt | N/A | N/A | N/A | $713K | N/A | N/A | N/A | N/A |
| Total Equity | -$34.0M+71.5% | -$119.2M-8.4% | -$110.0M-3057.8% | -$3.5M-462.3% | -$619K-65.7% | -$374K+93.7% | -$5.9M-24060.9% | $25K |
| Retained Earnings | -$152.2M-21.8% | -$125.0M-3511.7% | -$3.5M+0.7% | -$3.5M-461.9% | -$620K-65.6% | -$374K+93.7% | -$5.9M | N/A |
NVACW Cash Flow Statement
| Metric | Q3'25 | Q3'24 | Q4'23 | Q3'23 | Q4'22 | Q3'22 | Q4'21 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$10.6M-2098.8% | $531K+253.9% | -$345K+28.0% | -$480K-167.5% | -$179K-66.3% | -$108K | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$7.5M-1735.7% | $458K+699.3% | -$76K-151.7% | $148K+399775.7% | -$37 | $0 | N/A | N/A |
| Financing Cash Flow | $20.9M+700.8% | -$3.5M-952.6% | $409K+19.0% | $343K | N/A | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $0-100.0% | $595K | $0 | $0 | N/A | N/A | N/A | N/A |
NVACW Financial Ratios
| Metric | Q3'25 | Q3'24 | Q4'23 | Q3'23 | Q4'22 | Q3'22 | Q4'21 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | -1470.7% | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | -3329.3% | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -522.2%-493.7pp | -28.4% | N/A | -3.4% | N/A | 0.9% | N/A | N/A |
| Current Ratio | 0.18+0.2 | 0.00-0.3 | 0.32+0.3 | 0.05-0.5 | 0.55-1.2 | 1.76-8.6 | 10.31 | N/A |
| Debt-to-Equity | -1.13-0.1 | -1.03+0.1 | -1.10-0.9 | -0.20+315.2 | -315.36+204.0 | -519.36-485.7 | -33.67 | N/A |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$119.2M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Frequently Asked Questions
Is Profusa Inc profitable?
No, Profusa Inc (NVACW) reported a net income of -$8.7M in fiscal year 2024.
What is Profusa Inc's earnings per share (EPS)?
Profusa Inc (NVACW) reported diluted earnings per share of $-1.47 for fiscal year 2024. This represents a -1325.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Profusa Inc's operating cash flow?
Profusa Inc (NVACW) generated -$1.3M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Profusa Inc's total assets?
Profusa Inc (NVACW) had $3.1M in total assets as of fiscal year 2024, including both current and long-term assets.
Does Profusa Inc buy back shares?
Yes, Profusa Inc (NVACW) spent $3.2M on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.
How many shares does Profusa Inc have outstanding?
Profusa Inc (NVACW) had 6M shares outstanding as of fiscal year 2024.
What is Profusa Inc's current ratio?
Profusa Inc (NVACW) had a current ratio of 0.00 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is Profusa Inc's debt-to-equity ratio?
Profusa Inc (NVACW) had a debt-to-equity ratio of -1.03 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Profusa Inc's return on assets (ROA)?
Profusa Inc (NVACW) had a return on assets of -283.5% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Profusa Inc's cash runway?
Based on fiscal year 2024 data, Profusa Inc (NVACW) had $191K in cash against an annual operating cash burn of $1.3M. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Profusa Inc's debt-to-equity ratio negative or unusual?
Profusa Inc (NVACW) has negative shareholder equity of -$119.2M as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Profusa Inc's Piotroski F-Score?
Profusa Inc (NVACW) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Profusa Inc's earnings high quality?
Profusa Inc (NVACW) has an earnings quality ratio of 0.15x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.